About Surgery Hemostat Powder
Hemostatic agents are used when medical hemostasis is insufficient or impractical. The majority of routine, elective processes are achieved in patients with normal hemostasis and with negligible blood loss. The two main classifications of topical hemostatic agents are physical agents, which endorse hemostasis using a passive substrate, and biologically active agents, which improve coagulation at the bleeding site.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Competition among existing players is due to the Surgery Hemostat Powder market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Surgery Hemostat Powder Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Surgery Hemostat Powder market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Ethicon (United States), Biomup (France), BD (United States), Pfizer (United States), Gelita Medical (Germany), Equimedical (Netherlands), BioCer Entwicklungs-GmbH (Germany), Celox (United Kingdom), Hemotec Medical (Germany) and Starch Medical Inc. (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Surgery Hemostat Powder market by Type (Microfibrillar Collagen, Chitosan and Other), Application (Surgical Wound Care and General Wound Care) and Region.
On the basis of geography, the market of Surgery Hemostat Powder has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Packaging, the sub-segment i.e. Pouches will boost the Surgery Hemostat Powder market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological Advancements in the Products
Market Growth Drivers:
Rising Number of Surgical Procedures across the Globe and Increase in Vehicle Accidents and Sports-Related Surgeries
Challenges:
Shortage of Skilled Personnel
Restraints:
High Cost of the Hemostats
Opportunities:
Increasing Infrastructural Investment of Healthcare in Developing Countries
Market Leaders and their expansionary development strategies
In March 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, has announced the strategic regional launch of SURGICEL POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand. It is already available in Singapore and Hong Kong, and further launches are planned for later this year in Japan, Malaysia and India. This innovation is a powdered adjunctive hemostat that is designed to help surgeons control disruptive bleeding more efficiently.
In July 2024, Baxter International Inc., a global leader in advancing surgical innovation, announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.
On 1st April 2019, Johnson and Johnson announced that Ethicon Inc. has completed the acquisition of Auris Health Inc. With Auris Health’s robotic platform technology, currently used in diagnostic and therapeutic procedures in the lung, Johnson & Johnson will advance its commitment to combatting lung cancer and expand its digital surgery portfolio across multiple surgical specialties.
Key Target Audience
Manufacturers of Hemostat Powder, Suppliers of Hemostat Powder, Wholesalers, Distributors and Retailers of Hemostat Powder, Pharmaceutical Industry, Research Organizations and Governmental Bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.